Fortrea Holdings (FTRE) Interest Expenses (2022 - 2026)

Fortrea Holdings (FTRE) posted Interest Expenses of $23.4 million for Q1 2026, down 50.0% on a QoQ basis from $46.8 million in Q4 2025, and down 31.58% year-over-year from $34.2 million in Q1 2025.

Fortrea Holdings (FTRE) Interest Expenses (2022 - 2026) Analysis & Trends

Fortrea Holdings' Interest Expenses history runs 5 years deep, the most recent figure standing at $23.4 million for Q1 2026.

  • Quarterly Interest Expenses fell 31.58% year-over-year to $23.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $97.5 million (down 8.96% YoY) and the FY2025 annual result came in at $48.0 million, down 56.2% from the prior year.
  • Interest Expenses was $23.4 million for Q1 2026 at Fortrea Holdings, down from $46.8 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $60.1 million in Q2 2023 and bottomed at $100000.0 in Q1 2023.
  • A 5-year average of $34.8 million and a median of $32.8 million in 2024 frame the typical range for Interest Expenses.
  • Annual changes were most pronounced in 2024 — Interest Expenses jumped 50000.0% — and 2025, when it plunged 75.81%.
  • Fortrea Holdings' Interest Expenses stood at $50.3 million in 2022, then plunged by 40.16% to $30.1 million in 2023, then slumped by 62.46% to $11.3 million in 2024, then jumped by 314.16% to $46.8 million in 2025, then plunged by 50.0% to $23.4 million in 2026.
  • Business Quant data shows FTRE's Interest Expenses at $23.4 million in Q1 2026, $46.8 million in Q4 2025, and $27.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -42,141.15
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 32.89 Mn
4 NuCana 279.75 Bn 279.75 Bn - 16.81 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 420.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 28.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 1.17 Bn
10 Fortrea Holdings 1.83 Bn 1.68 Bn 123.60 Mn 23.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.40 Mn
Mar 31, 2026 23.40 Mn
Dec 31, 2025 46.80 Mn
Dec 31, 2025 46.80 Mn
Sep 30, 2025 27.90 Mn
Sep 30, 2025 27.90 Mn
Jun 30, 2025 12.00 Mn
Jun 30, 2025 12.00 Mn
Mar 31, 2025 34.20 Mn
Mar 31, 2025 34.20 Mn
Dec 31, 2024 11.30 Mn
Dec 31, 2024 11.30 Mn
Sep 30, 2024 31.50 Mn
Sep 30, 2024 31.50 Mn
Jun 30, 2024 49.60 Mn
Jun 30, 2024 49.60 Mn
Mar 31, 2024 50.10 Mn
Mar 31, 2024 50.10 Mn
Dec 31, 2023 30.10 Mn
Dec 31, 2023 30.10 Mn